US 11725207
Serpina1 iRNA compositions and methods of use thereof
granted A61PA61P1/16A61P35/00
Quick answer
US patent 11725207 (Serpina1 iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 123
- CPC classes
- A61P, A61P1/16, A61P35/00, A61P43/00